Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma. [electronic resource]
Producer: 20140306Description: 258-65 p. digitalISSN:- 1365-2141
- Adult
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- pharmacology
- Antineoplastic Agents -- pharmacology
- CD40 Antigens -- antagonists & inhibitors
- Female
- Hodgkin Disease -- drug therapy
- Humans
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Neoplasm Staging
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.